8:40am ET
Health and Healthcare
Major Biopharma Catalysts and FDA Events to Look For in March
24/7 Wall St. includes a calendar of a few of the biggest companies expecting clinical trial and FDA updates in the month of March.
Companies
/Healthcare
ImmunoGen
$31.23
â–² $0.00 (+0.00%) today
Markets open · 1:22pm ET
IMGN Coverage
Page 29:05am ET
Investing
Top Analyst Upgrades and Downgrades: AK Steel, Apple, Biogen, EA, FitBit, Foot Locker, McDonald’s, Pfizer and More
The top analyst upgrades, downgrades and other research calls from Wednesday include AK Steel, Apple, Biogen, Electronic Arts, FitBit, Foot Locker, McDonald's and Pfizer.
9:40am ET
Health and Healthcare
ImmunoGen Shares Collapse After Huge Miss on Profits, Revenues
Cancer drug developer ImmunoGen posted sharply lower profits and revenues than analysts were expecting. The stock is taking a beating as a result.
Paul Ausick 9:55am ET
Health and Healthcare
Why ImmunoGen’s Secondary Makes Sense
ImmunoGen saw its shares make a sharp turn downward on Thursday morning after the stock has seen an incredible year of trading so far.
Chris Lange 1:05pm ET
Health and Healthcare
ImmunoGen Riding High on Jazz Pharma Deal
ImmunoGen announced this week that it has decided to partner with Jazz Pharmaceuticals, and investors have pushed Immunogen shares to a new 52-week high.
10:10am ET
Health and Healthcare
ImmunoGen and Jazz Enter Into Global Collaboration
ImmunoGen has decided to partner with Jazz Pharmaceuticals for the development and commercialization of two early-stage, hematology-related antibody-drug conjugate programs.
8:55am ET
Investing
Top Analyst Upgrades and Downgrades: AutoZone, O’Reilly Automotive, Immunogen, Medtronic, Nike, OncoSec, Schlumberger and More
The top analyst upgrades, downgrades and other research calls from Thursday include AutoZone, O'Reilly Automotive, Immunogen, Medtronic, Nike, OncoSec Medical and Schlumberger.
8:45am ET
Investing
Top Analyst Upgrades and Downgrades: Amarin, Amex, Barrick Gold, Cameco, Groupon, ImmunoGen, JPMorgan, Whole Foods and More
The top analyst upgrades, downgrades and other research calls from Thursday include Amarin, American Express, Barrick Gold, Cameco, Groupon, ImmunoGen, JPMorgan and Whole Foods Market.
1:55pm ET
Health and Healthcare
ImmunoGen Rises Following Licensing Update With Sanofi
ImmunoGen watched its stock make a handy gain after the firm announced that had amended its license agreements with Sanofi.
Chris Lange 4:04pm ET
Investing
Staples, Teva Join Friday’s 52-Week Low Club
October 14, 2016: Here are four stocks trading with relatively heavy volume among 57 equities making new 52-week lows in Friday’s session. On the NYSE, advancers led decliners by just better than…
4:04pm ET
Investing
Autohome, ImmunoGen Lead Friday’s 52-Week Low Club
July 15, 2016: Here are four stocks trading with relatively heavy volume among just 11 equities making new 52-week lows in Friday’s session. Volumes only rose above 1 million for two of…
4:04pm ET
Investing
ImmunoGen, CVR Top Thursday’s 52-Week Low Club
July 14, 2016: Here are four stocks trading with relatively heavy volume among just 13 equities making new 52-week lows in Thursday’s session. Volumes did not rise about 1 million for any…
4:04pm ET
Investing
CVR Refining, ImmunoGen Join Wednesday’s 52-Week Low Club
July 13, 2016: Here are four stocks trading with relatively heavy volume among 11 equities making new 52-week lows in Wednesday’s session. NYSE decliners led advancers by a small margin and Nasdaq…
Paul Ausick 4:07pm ET
Investing
The 52-Week Low Club for Wednesday
June 15, 2016: Here are four stocks trading with relatively heavy volume among 28 equities making new 52-week lows in Wednesday’s session. NYSE advancers led decliners by less than 2 to 1…
4:04pm ET
Investing
The 52-Week Low Club for Tuesday
June 14, 2016: Here are four stocks trading with relatively heavy volume among 97 equities making new 52-week lows in Tuesday’s session. NYSE decliners led advancers by about 2 to 1 while…